Race and ethnicity appear to play an important a role in the link between psychedelic use and mental health outcomes

New research has found that race and ethnicity moderate the associations between the use of psychedelic drugs and major depressive episodes in a large, nationally representative sample of U.S. adults. The findings have been published in the Journal of Psychopharmacology. In recent years, psychedelic substances such as MDMA and psilocybin have undergone clinical studies to explore their potential therapeutic benefits, with promising results in areas including depression and anxiety. However, this research is still in its earliest stages, and little is known about the relationship between race a…

Read More

View the full article